Menesit



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 50.0%
Parkinson's Disease 25.0%
Parkinsonism 25.0%
Cardio-respiratory Arrest 20.0%
Hypoglycaemia 20.0%
Posture Abnormal 20.0%
Syncope 20.0%
Therapeutic Response Decreased 20.0%
Secondary
Parkinson's Disease 64.3%
Constipation 6.7%
Drug Effect Decreased 5.3%
Depression 3.1%
Anxiety 2.6%
Gastritis 2.6%
Dementia With Lewy Bodies 1.9%
Glaucoma 1.4%
Hyperlipidaemia 1.2%
Hypertension 1.2%
Parkinsonism 1.2%
Back Pain 1.0%
Benign Prostatic Hyperplasia 1.0%
Dermatitis Atopic 1.0%
Drug Use For Unknown Indication 1.0%
Hypoaesthesia 1.0%
Insomnia 1.0%
Muscle Tightness 1.0%
Type 2 Diabetes Mellitus 1.0%
Abdominal Pain Upper 0.7%
Poriomania 13.6%
Neuroleptic Malignant Syndrome 12.3%
Posture Abnormal 7.4%
Tremor 6.2%
Vomiting 6.2%
Hallucination 4.9%
Psychiatric Symptom 4.9%
Sexual Activity Increased 4.9%
Delirium 3.7%
Gait Disturbance 3.7%
Orthostatic Hypotension 3.7%
Parkinson's Disease 3.7%
Pneumonia Aspiration 3.7%
Salivary Hypersecretion 3.7%
Somnolence 3.7%
Thirst 3.7%
Ruptured Cerebral Aneurysm 2.5%
Speech Disorder 2.5%
Subarachnoid Haemorrhage 2.5%
Unevaluable Event 2.5%
Concomitant
Parkinson's Disease 53.8%
Constipation 7.8%
Hypertension 7.5%
Insomnia 4.0%
Depression 3.3%
Drug Use For Unknown Indication 2.7%
Gastritis 2.3%
Dementia 2.2%
Diabetes Mellitus 2.0%
Hepatic Cirrhosis 2.0%
Nocardiosis 1.9%
Osteoporosis 1.8%
Parkinsonism 1.8%
Abdominal Discomfort 1.3%
Hyperlipidaemia 1.2%
Multiple Sclerosis 1.1%
Pollakiuria 1.0%
Drug Effect Decreased 0.9%
Herpes Zoster 0.9%
Back Pain 0.8%
Sudden Onset Of Sleep 13.8%
Tremor 7.5%
Interstitial Lung Disease 6.9%
Parkinsonism 6.3%
Pleural Effusion 6.3%
Hallucination 5.6%
Posture Abnormal 5.6%
Somnolence 5.0%
White Blood Cell Count Decreased 5.0%
Neuroleptic Malignant Syndrome 4.4%
Parkinson's Disease 4.4%
White Blood Cell Count Increased 4.4%
Loss Of Consciousness 3.8%
Pneumonia 3.8%
Death 3.1%
Renal Failure Chronic 3.1%
Restless Legs Syndrome 3.1%
Sudden Death 3.1%
Cardiac Valve Disease 2.5%
Fall 2.5%